On

Oncologist

The Oncologist is a journal focused on oncology and hematology and publishes timely reviews, original studies, and commentaries on important developments in the field.

Looking to publish in Oncologist? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 4.2
Quartile Q2
Open Access Type Hybrid
ISSN 1083-7159
eISSN 1549-490X
Invitation Only No
Cost Range Article Processing Charges usually apply for fully open access journals and for gold open access in hybrid journals; waivers or discounts are available for corresponding authors in qualifying low- and middle-income countries publishing in fully open access journals.

Submission Instructions

Oncologist accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter A cover letter should accompany the submission. The cover letter must briefly describe the work’s significance and identify the corresponding author with their complete mailing address.
Abstract Original Articles must include an abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background, Materials and Methods or Patients and Methods, Results, and Conclusion.
Manuscript The manuscript text must not exceed 4,000 words. The text should be organized in the following order when appropriate: Introduction, Materials and Methods, Results, Discussion, Conclusion and/or Summary, Acknowledgments, Disclosure of Potential Conflicts of Interest, Author Contributions, Data Availability Statement, References, Figure legends, Tables, and Figures. Original Articles must include an Implications for Practice statement of less than 100 words that clearly explains the manuscript’s potential clinical impact in language comprehensible to a lay reader whenever possible.
References References must not exceed 100 entries. References must follow American Medical Association parent style. References must be numbered in the order in which they are cited in the text.
Figures & Tables Original Articles may include a maximum of 7 display items. Tables must not be embedded within the manuscript and must be submitted as separate .doc files, and each figure must be submitted as an individual image file with legends included in the manuscript. Tables and figures must be numbered in the order cited in the text, tables must be titled, and figures must have legends.
Reformat to Oncologist using Livewrite Premium

Review Article

Cover Letter A cover letter should accompany the submission. The cover letter must briefly describe the work’s significance and identify the corresponding author with the corresponding author’s complete mailing address.
Abstract An abstract is required for Review Articles. The abstract must not exceed 250 words. The abstract may be structured or unstructured at the authors’ preference.
Manuscript The manuscript must not exceed 4,000 words. The text should be divided in order into Introduction, Materials and Methods, Results, Discussion, Conclusion and/or Summary, Acknowledgments, Disclosure of Potential Conflicts of Interest, Author Contributions, Data Availability Statement, References, Figure legends, Tables, and Figures when appropriate, and Review Articles must include a Materials and Methods section detailing how the literature review was planned, selection criteria, use of levels of evidence, and whether unpublished material was included. Review Articles must include an Implications for Practice statement of less than 100 words that clearly defines the manuscript’s potential clinical impact in lay-comprehensible language whenever possible.
References References must not exceed 150. References must follow American Medical Association parent style. References must be numbered in the order they are cited in the text.
Figures & Tables Review Articles must not exceed 7 figures and tables in total, and additional figures or tables should be provided as supplementary material. Tables must not be embedded within the manuscript, tables must be submitted as individual .doc files, figure titles and legends must appear in the manuscript file, and each figure must be submitted as an individual image file. Tables and figures must be numbered in the order they are cited in the text, tables must be titled, and figures must have a legend.
Reformat to Oncologist using Livewrite Premium

Clinical Trial Results

Cover Letter A cover letter should accompany the submission. Cover letter must briefly describe the work’s significance and identify the corresponding author with the corresponding author’s complete mailing address.
Abstract Abstract is required. Abstract must be 250 words or less. Abstract must be structured. Abstract must include the headings Background, Methods, Results, and Conclusion, and the conclusion must include the ClinicalTrials.gov identifier.
Manuscript Main text must not exceed 1,500 words, and the Discussion section should be less than 1000 words. Manuscript must use the CTR submission template and include Lessons Learned, trial information, drug information, study arm details, patient cohort description, assessment methods, response assessments, toxicity tables, and a Discussion stating whether the study was completed or terminated and summarizing the investigators’ assessment. Manuscript must include 1 to 3 bullet-point Lessons Learned and four to six keywords or phrases on the first page.
References References must follow AMA style. References must be numbered in the order in which they are cited in the text.
Figures & Tables There is no firm figure or table count limit. Additional figures and tables should be placed at the end of the file in the Figures and Tables section, while journal-level table instructions also state that tables must not be embedded within the manuscript and must be submitted as individual .doc files. Tables must be provided as text rather than images, additional tables must match the template formatting, serious adverse events tables must report one patient per row, general toxicity profiles must use CTCAE, and Dose Limiting Toxicities must be presented in table format.
Reformat to Oncologist using Livewrite Premium

Brief Communications

Cover Letter A cover letter should accompany the submission. Cover letter must briefly describe the work’s significance and identify the corresponding author with the corresponding author’s complete mailing address.
Abstract Text abstract is required.
Manuscript Manuscript is limited to 1,000 words. The first page must include four to six keywords or phrases.
References References are limited to 10. References must follow American Medical Association parent style. References must be numbered in the order in which they are cited in the text.
Figures & Tables Brief Communications may include a maximum of 2 display items. Tables must not be embedded within the manuscript, tables must be submitted as individual files, figure legends must be included in the manuscript file, and each figure must be submitted as an individual image file. Tables, figures, and legends must be numbered in the order in which they are cited in the text.
Reformat to Oncologist using Livewrite Premium

Precision Medicine Clinic: Molecular Tumor Board

Cover Letter A cover letter should accompany the submission and briefly describe the work’s significance while identifying the corresponding author and giving the corresponding author’s complete mailing address. The cover letter must briefly describe the work’s significance, identify the corresponding author, and include the corresponding author’s complete mailing address.
Abstract An abstract is required.
Manuscript Manuscript length is limited to 2,000 words. Manuscript must include an Abstract, Key Points, a Patient Story, a Molecular Tumor Board section, a Patient update, References, Figures, Tables, and a Glossary of genomic terms and nomenclature. The Molecular Tumor Board section must include genotyping results and interpretation of the molecular results, the functional and clinical significance of the specific mutation in the particular cancer, and potential strategies to target the pathway with implications for clinical practice.
References References are limited to a maximum of 25. References must follow American Medical Association parent style. References must be numbered in the order in which they are cited in the text.
Figures & Tables Submissions may include up to 4 display items. Tables must not be embedded within the manuscript and must be submitted as individual files, while figure titles and legends must be included in the manuscript file and each figure submitted as an individual image file. Tables are required, including considerations for clinical management while reviewing a molecular alteration report in clinic, and figures must have legends.
Reformat to Oncologist using Livewrite Premium

Letters To The Editor

Cover Letter Cover letter should accompany the submission. Cover letter must briefly describe the work's significance and identify the corresponding author with their complete mailing address.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must not exceed 500 words. Letters to the Editor must pertain to papers published in the past year. The first page must include a title of no more than 150 characters, a running head of no more than 50 characters, author names, Author Contributions using CRediT, main-text word count, any disclaimers, a brief acknowledgment of support, and four to six MeSH-based keywords or phrases.
References Letters to the Editor may include no more than 10 references. References must follow AMA parent style. References must be numbered in the order they are cited in the text.
Figures & Tables Letters to the Editor may include a maximum of 1 display item. Tables must not be embedded within the manuscript, must be submitted as individual .doc files, and figure legends must appear in the manuscript while each figure is uploaded as an individual file. Tables and figures must be numbered in the order cited, tables must be titled, and all images must include alt text placed under the relevant figure legend in the manuscript.
Reformat to Oncologist using Livewrite Premium

Recent Publications

Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC)

Anup Kasi, Raed Moh’d Taiseer Al-Rajabi, Joaquina Celebre Baranda, Anwaar Saeed, Junqiang Dai, Prabhakar Chalise, Scott Weir, Brent Sear, Erin Carroll, Shannon Bradbury, Alok Tripathi, Stephen Hyter, Venkatadri Beeki, Richard J McKittrick, Sean Kumer, Timothy Schmitt, Steven Soper, Andrew K Godwin, Weijing Sun

10.1093/oncolo/oyag225
View Publication

Transformation of ALK-translocated lung adenocarcinoma to LCNEC under alectinib treatment–a case report and mini-review

Josef Kim, Lars Uwe Stephan, Konrad Steinestel, Yasir Arafat Tamal, Annette Arndt, Thomas Barck

10.1093/oncolo/oyag226
View Publication

Dynamic Therapeutic Response to Osimertinib and Immunotherapy in an EGFR L747S and L858R co-mutant NSCLC

Yuqing Tan, Tengfei Wang, Jing Yu, Wen Ouyang

10.1093/oncolo/oyag227
View Publication

Hepatic Arterial Infusion Chemotherapy for Metastatic Colorectal Cancer: Real-World Outcomes of Intensification and Salvage Strategies

Annalice Gandini, Federico Lipsich, Jeanne Netter-Coti, Widad Lahlou, Celine Lepere, Xavier Guerra, Olivier Pellerin, Julien Taieb, Tom Boeken, Claire Gallois

10.1093/oncolo/oyag214
View Publication

Multidisciplinary Clinics in Cancer—Models, Metrics, and Meaning: A Review

Seohyuk Lee, Jim W Doolin, David E Avigan, Stefan Balan, Peter Chang, Kristen Crowell, Martin Dib, Kelly Downey, Charly Edmiston, Panagiotis Fidias, Jason A Freed, Leslie A Garrett, Lauren Hertan, Scharukh Jalisi, David McDermott, Evangelos Messaris, Umut Sarpel, Ammar Sarwar, Meghan Shea, Rafael Vega, Peter D Whooley, Jennifer L Wilson, Elizabeth A Mittendorf, Jessica A Zerillo

10.1093/oncolo/oyag208
View Publication

Frequently asked questions

How long does it take to publish?

Accepted Manuscript is published within one week after acceptance and signing the publishing agreement.

Reformat to Oncologist using Livewrite Premium

Is a cover letter required?

Submissions should be accompanied by a cover letter briefly describing the work’s significance and identifying the corresponding author, including complete mailing address, telephone number, and email address. The cover letter must also disclose related or similar previously published or under-consideration materials.

Reformat to Oncologist using Livewrite Premium

What are the publication costs?

Article Processing Charges usually apply for fully open access journals and for gold open access in hybrid journals; waivers or discounts are available for eligible corresponding authors in qualifying countries publishing in fully open access journals.

Reformat to Oncologist using Livewrite Premium

Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies Cancer Treatment and Pharmacology Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Cancer Genomics and Diagnostics Lung Cancer Research Studies Cancer survivorship and care Economic and Financial Impacts of Cancer Renal cell carcinoma treatment Advanced Breast Cancer Therapies Pancreatic and Hepatic Oncology Research Global Cancer Incidence and Screening Lymphoma Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis Palliative Care and End-of-Life Issues Lung Cancer Diagnosis and Treatment Gastric Cancer Management and Outcomes Neuroendocrine Tumor Research Advances Prostate Cancer Treatment and Research Health Systems, Economic Evaluations, Quality of Life Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer Head and Neck Cancer Studies

Related Journals

JO
Journal Of Thoracic Oncology Elsevier BV
JO
Jco Oncology Practice LIPPINCOTT WILLIAMS & WILKINS
MC
Molecular Cancer Therapeutics American Association for Cancer Research
CC
Cancer Cell CELL PRESS
CR
Critical Reviews In Oncology Hematology Elsevier BV
EJ
European Journal Of Oncology Nursing Elsevier BV